Aforti Holding SA operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aforti Holding SA with three other
financial institutions in Europe:
BB Biotech AG
sales of 240.87 million Swiss Francs [US$250.38 million]
of which 100%
was Investing & Related Activity),
HBM Healthcare Investments AG
(265.91 million Swiss Francs [US$276.41 million]
Blue Cap AG
based in GERMANY
(232.55 million Euros [US$259.83 million]
of which 31%
was Plastics Technology).
During the year ended December of 2019, sales at
Aforti Holding SA were 1.04 billion Polish New Zlotys (US$264.02 million).
increase of 81.2%
versus 2018, when the company's sales were 572.01 million Polish New Zlotys.
This was the fifth consecutive year of sales increases at Aforti Holding SA
(and since 2014, sales have increased a total of 9,054%).